
- Applied Clinical Trials-09-01-2024
- Volume 33
- Issue 9
Aligning Technology and Oversight
Amid the steady introduction of new tech and data advances in study conduct, the September issue of Applied Clinical Trials explores the evolving regulatory landscape governing these efforts and what companies are doing to remain compliant.
Throughout 2024, we have witnessed a multitude of advancements in the clinical research industry—many of them in technology. In a space that is so closely regulated, it is remarkable that sponsors and their service-provider partners are continuing to find new and innovative ways to bring therapies to patients faster. In this September issue of
Our quartet of feature articles begins with
Our
As evidenced by our coverage, the regulatory landscape is constantly evolving. For the latest insights and news in this space, stay tuned to our website. As always, thank you for reading.
Mike Hennessy Jr is president and CEO of MJH Life Sciences®
Articles in this issue
about 1 year ago
Applied Clinical Trials September 2024 Issue (PDF)about 1 year ago
A New Regulatory Road in Clinical Trials: Digital Twinsabout 1 year ago
Regulatory CMC: Enhancing Biologics Developmentabout 1 year ago
Driving Inclusion in Clinical Trials: Less Talk, More Trustabout 1 year ago
Risk Planning: A Review of Industry TrendsNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.